✦ LIBER ✦

Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia

✍ Scribed by Katsuya Yamamoto; Kimikazu Yakushijin; Yuriko Kawamori; Kentaro Minagawa; Yoshio Katayama; Toshimitsu Matsui

Book ID: 113513125
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 778 KB
Volume: 176
Category: Article
ISSN: 0165-4608
DOI: 10.1016/j.cancergencyto.2007.02.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Translocation (2;11)(q37;q23) in therapy

Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia

✍ Simone Snijder; Clemens H.M. Mellink; Hans van der Lelie 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Translocation (5;9)(q22;q34) in a Case o

Translocation (5;9)(q22;q34) in a Case of Acute Lymphoblastic Leukemia with Multiple Bone Involvement: Effectiveness of Donor Lymphocyte Infusion for Relapse after Allogeneic Stem Cell Transplantation

✍ Hideki Tsujimura; Kyoya Kumagai; Akira Yokota; Mitsuro Narita; Chikara Sakai; To 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 906 KB

Bone marrow transplantation for therapy-

Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome

✍ C. Hon; G.C.F. Chan; S.Y. Ha; S.K. Ma; K.F. Wong; W.Y. Au 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 109 KB

Prediction of therapy-related acute myel

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma

✍ Legare, Robert D.; Gribben, John G.; Maragh, Marlon; Hermanowski-Vosatka, Anne; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th

13: The Outcome of Allogeneic Stem Cell

13: The Outcome of Allogeneic Stem Cell Transplantation (alloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML) Varies Considerably by Risk Factor: An Observational Study From the Center for International Blood and Marrow Transplant Research (CIBMTR)

✍ M.R. Litzow; W.S. Pérez; S. Tarima; A. Keating; J. Sierra; M.S. Tallman; D.J. We 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB